The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

doi:10.1084/jem.178.2.489

This Article

	Full Text (PDF, 626K)
	Alert me when this article is cited
	Citation Map

Services

	Email this article
	Similar articles in this journal
	Similar articles in PubMed
	Alert me to new content in the JEM
	Download to citation manager

Citing Articles

	Citing Articles via HighWire
	Citing Articles via CrossRef
	Citing Articles via Google Scholar

Google Scholar

	Articles by Brichard, V.
	Articles by Boon, T.
	Search for Related Content

PubMed

	PubMed Citation
	Articles by Brichard, V.
	Articles by Boon, T.


Social Bookmarking

	What's this?

ARTICLES

The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas

V Brichard, A Van Pel, T Wolfel, C Wolfel, E De Plaen, B Lethe, P Coulie and T Boon
Ludwig Institute for Cancer Research, Brussels Branch, Belgium.

Lymphocytes of melanoma patients can be restimulated in vitro with autologous tumor cells to generate antitumor cytolytic T lymphocytes (CTL). Previous reports have indicated that, when such CTL are obtained from HLA-A2 melanoma patients, they often display broad reactivity on A2 melanoma cell lines. Such antitumor CTL clones, which appeared to recognize the same antigen, were isolated from two patients. We report here the cloning of a cDNA that directs the expression of the antigen recognized by these CTL. This cDNA corresponds to the transcript of the tyrosinase gene. The gene was found to be active in all tested melanoma samples and in most melanoma cell lines. Among normal cells, only melanocytes appear to express the gene. The tyrosinase antigen presented by HLA-A2 may therefore constitute a useful target for specific immunotherapy of melanoma. But possible adverse effects of antityrosinase immunization, such as the destruction of normal melanocytes and its consequences, will have to be examined before clinical pilot studies can be undertaken.
Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

Godet, Y., Moreau-Aubry, A., Guilloux, Y., Vignard, V., Khammari, A., Dreno, B., Jotereau, F., Labarriere, N. (2008). MELOE-1 is a new antigen overexpressed in melanomas and involved in adoptive T cell transfer efficiency. JEM 205: 2673-2682 [Abstract] [Full Text]
Schuler, P., Contassot, E., Irla, M., Hugues, S., Preynat-Seauve, O., Beermann, F., Donda, A., French, L.E., Huard, B. (2008). Direct Presentation of a Melanocyte-Associated Antigen in Peripheral Lymph Nodes Induces Cytotoxic CD8+ T Cells. Cancer Res. 68: 8410-8418 [Abstract] [Full Text]
Santegoets, S. J. A. M., Schreurs, M. W. J., Reurs, A. W., Lindenberg, J. J., Kueter, E. W. M., van den Eertwegh, A. J. M., Hooijberg, E., Brandwijk, R. J., Hufton, S. E., Hoogenboom, H. R., Scheper, R. J., Somers, V. A., de Gruijl, T. D. (2007). Identification and Characterization of ErbB-3-Binding Protein-1 as a Target for Immunotherapy. J. Immunol. 179: 2005-2012 [Abstract] [Full Text]
Nichols, L. A., Chen, Y., Colella, T. A., Bennett, C. L., Clausen, B. E., Engelhard, V. H. (2007). Deletional Self-Tolerance to a Melanocyte/Melanoma Antigen Derived from Tyrosinase Is Mediated by a Radio-Resistant Cell in Peripheral and Mesenteric Lymph Nodes. J. Immunol. 179: 993-1003 [Abstract] [Full Text]
Sabbatini, P., Odunsi, K. (2007). Immunologic Approaches to Ovarian Cancer Treatment. JCO 25: 2884-2893 [Abstract] [Full Text]
Preynat-Seauve, O., Contassot, E., Schuler, P., Piguet, V., French, L. E., Huard, B. (2007). Extralymphatic Tumors Prepare Draining Lymph Nodes to Invasion via a T-Cell Cross-Tolerance Process. Cancer Res. 67: 5009-5016 [Abstract] [Full Text]
Walton, S. M., Gerlinger, M., de la Rosa, O., Nuber, N., Knights, A., Gati, A., Laumer, M., Strauss, L., Exner, C., Schafer, N., Urosevic, M., Dummer, R., Tiercy, J.-M., Mackensen, A., Jaeger, E., Levy, F., Knuth, A., Jager, D., Zippelius, A. (2006). Spontaneous CD8 T Cell Responses against the Melanocyte Differentiation Antigen RAB38/NY-MEL-1 in Melanoma Patients. J. Immunol. 177: 8212-8218 [Abstract] [Full Text]
Perales, M.-A., Diab, A., Cohen, A. D., Huggins, D. W., Guevara-Patino, J. A., Hubbard, V. M., Engelhorn, M. E., Kochman, A. A., Eng, J. M., Mortazavi, F., Alpdogan, O., Terwey, T. H., Heller, G., Wolchok, J. D., Houghton, A. N., van den Brink, M. R. M. (2006). DNA Immunization against Tissue-Restricted Antigens Enhances Tumor Immunity after Allogeneic Hemopoietic Stem Cell Transplantation. J. Immunol. 177: 4159-4167 [Abstract] [Full Text]
Cohen, A. D., Diab, A., Perales, M.-A., Wolchok, J. D., Rizzuto, G., Merghoub, T., Huggins, D., Liu, C., Turk, M. J., Restifo, N. P., Sakaguchi, S., Houghton, A. N. (2006). Agonist Anti-GITR Antibody Enhances Vaccine-Induced CD8+ T-Cell Responses and Tumor Immunity.. Cancer Res. 66: 4904-4912 [Abstract] [Full Text]
MacGregor, J. N., Li, Q., Chang, A. E., Braun, T. M., Hughes, D. P.M., McDonagh, K. T. (2006). Ex vivo Culture with Interleukin (IL)-12 Improves CD8+ T-Cell Adoptive Immunotherapy for Murine Leukemia Independent of IL-18 or IFN-{gamma} but Requires Perforin.. Cancer Res. 66: 4913-4921 [Abstract] [Full Text]
Hodi, F. S. (2006). Well-Defined Melanoma Antigens as Progression Markers for Melanoma: Insights into Differential Expression and Host Response Based on Stage. Clin. Cancer Res. 12: 673-678 [Full Text]
Goldberg, S. M., Bartido, S. M., Gardner, J. P., Guevara-Patino, J. A., Montgomery, S. C., Perales, M.-A., Maughan, M. F., Dempsey, J., Donovan, G. P., Olson, W. C., Houghton, A. N., Wolchok, J. D. (2005). Comparison of Two Cancer Vaccines Targeting Tyrosinase: Plasmid DNA and Recombinant Alphavirus Replicon Particles. Clin. Cancer Res. 11: 8114-8121 [Abstract] [Full Text]
Yoshiura, K., Nakaoka, T., Nishishita, T., Sato, K., Yamamoto, A., Shimada, S., Saida, T., Kawakami, Y., Takahashi, T. A., Fukuda, H., Imajoh-Ohmi, S., Oyaizu, N., Yamashita, N. (2005). Carbonic Anhydrase II Is a Tumor Vessel Endothelium-Associated Antigen Targeted by Dendritic Cell Therapy. Clin. Cancer Res. 11: 8201-8207 [Abstract] [Full Text]
Lennerz, V., Fatho, M., Gentilini, C., Frye, R. A., Lifke, A., Ferel, D., Wolfel, C., Huber, C., Wolfel, T. (2005). The response of autologous T cells to a human melanoma is dominated by mutated neoantigens. Proc. Natl. Acad. Sci. USA 102: 16013-16018 [Abstract] [Full Text]
Vignard, V., Lemercier, B., Lim, A., Pandolfino, M.-C., Guilloux, Y., Khammari, A., Rabu, C., Echasserieau, K., Lang, F., Gougeon, M.-L., Dreno, B., Jotereau, F., Labarriere, N. (2005). Adoptive Transfer of Tumor-Reactive Melan-A-Specific CTL Clones in Melanoma Patients Is Followed by Increased Frequencies of Additional Melan-A-Specific T Cells. J. Immunol. 175: 4797-4805 [Abstract] [Full Text]
Hamamura, K., Furukawa, K., Hayashi, T., Hattori, T., Nakano, J., Nakashima, H., Okuda, T., Mizutani, H., Hattori, H., Ueda, M., Urano, T., Lloyd, K. O., Furukawa, K. (2005). Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells. Proc. Natl. Acad. Sci. USA 102: 11041-11046 [Abstract] [Full Text]
Nagata, Y., Hanagiri, T., Takenoyama, M., Fukuyama, T., Mizukami, M., So, T., Ichiki, Y., Sugaya, M., Sugio, K., Yasumoto, K. (2005). Identification of the HLA-Cw*0702-Restricted Tumor-Associated Antigen Recognized by a CTL Clone from a Lung Cancer Patient. Clin. Cancer Res. 11: 5265-5272 [Abstract] [Full Text]
Godefroy, E., Moreau-Aubry, A., Diez, E., Dreno, B., Jotereau, F., Guilloux, Y. (2005). {alpha}v{beta}3-dependent cross-presentation of matrix metalloproteinase-2 by melanoma cells gives rise to a new tumor antigen. JEM 202: 61-72 [Abstract] [Full Text]
van Rhee, F., Szmania, S. M., Zhan, F., Gupta, S. K., Pomtree, M., Lin, P., Batchu, R. B., Moreno, A., Spagnoli, G., Shaughnessy, J., Tricot, G. (2005). NY-ESO-1 is highly expressed in poor-prognosis multiple myeloma and induces spontaneous humoral and cellular immune responses. Blood 105: 3939-3944 [Abstract] [Full Text]
Germeau, C., Ma, W., Schiavetti, F., Lurquin, C., Henry, E., Vigneron, N., Brasseur, F., Lethe, B., De Plaen, E., Velu, T., Boon, T., Coulie, P. G. (2005). High frequency of antitumor T cells in the blood of melanoma patients before and after vaccination with tumor antigens. JEM 201: 241-248 [Abstract] [Full Text]
van Dinten, L. C., Pul, N., van Nieuwpoort, A. F., Out, C. J., Jager, M. J., van den Elsen, P. J. (2005). Uveal and Cutaneous Melanoma: Shared Expression Characteristics of Melanoma-Associated Antigens. IOVS 46: 24-30 [Abstract] [Full Text]
Uchida, N., Tsunoda, T., Wada, S., Furukawa, Y., Nakamura, Y., Tahara, H. (2004). Ring Finger Protein 43 as a New Target for Cancer Immunotherapy. Clin. Cancer Res. 10: 8577-8586 [Abstract] [Full Text]
Nakatsura, T., Komori, H., Kubo, T., Yoshitake, Y., Senju, S., Katagiri, T., Furukawa, Y., Ogawa, M., Nakamura, Y., Nishimura, Y. (2004). Mouse Homologue of a Novel Human Oncofetal Antigen, Glypican-3, Evokes T-Cell-Mediated Tumor Rejection without Autoimmune Reactions in Mice. Clin. Cancer Res. 10: 8630-8640 [Abstract] [Full Text]
Monji, M., Nakatsura, T., Senju, S., Yoshitake, Y., Sawatsubashi, M., Shinohara, M., Kageshita, T., Ono, T., Inokuchi, A., Nishimura, Y. (2004). Identification of a Novel Human Cancer/Testis Antigen, KM-HN-1, Recognized by Cellular and Humoral Immune Responses. Clin. Cancer Res. 10: 6047-6057 [Abstract] [Full Text]
Yang, S., Haluska, F. G. (2004). Treatment of Melanoma with 5-Fluorouracil or Dacarbazine In Vitro Sensitizes Cells to Antigen-Specific CTL Lysis through Perforin/Granzyme- and Fas-Mediated Pathways. J. Immunol. 172: 4599-4608 [Abstract] [Full Text]
Mine, T., Sato, Y., Noguchi, M., Sasatomi, T., Gouhara, R., Tsuda, N., Tanaka, S., Shomura, H., Katagiri, K., Rikimaru, T., Shichijo, S., Kamura, T., Hashimoto, T., Shirouzu, K., Yamada, A., Todo, S., Itoh, K., Yamana, H. (2004). Humoral Responses to Peptides Correlate with Overall Survival in Advanced Cancer Patients Vaccinated with Peptides Based on Pre-existing, Peptide-Specific Cellular Responses. Clin. Cancer Res. 10: 929-937 [Abstract] [Full Text]
Fleischer, K., Schmidt, B., Kastenmuller, W., Busch, D. H., Drexler, I., Sutter, G., Heike, M., Peschel, C., Bernhard, H. (2004). Melanoma-Reactive Class I-Restricted Cytotoxic T Cell Clones Are Stimulated by Dendritic Cells Loaded with Synthetic Peptides, but Fail to Respond to Dendritic Cells Pulsed with Melanoma-Derived Heat Shock Proteins In Vitro. J. Immunol. 172: 162-169 [Abstract] [Full Text]
Dadaglio, G., Morel, S., Bauche, C., Moukrim, Z., Lemonnier, F. A., Van den Eynde, B. J., Ladant, D., Leclerc, C. (2003). Recombinant adenylate cyclase toxin of Bordetella pertussis induces cytotoxic T lymphocyte responses against HLA*0201-restricted melanoma epitopes. Int Immunol 15: 1423-1430 [Abstract] [Full Text]
Benlalam, H., Linard, B., Guilloux, Y., Moreau-Aubry, A., Derre, L., Diez, E., Dreno, B., Jotereau, F., Labarriere, N. (2003). Identification of Five New HLA-B*3501-Restricted Epitopes Derived from Common Melanoma-Associated Antigens, Spontaneously Recognized by Tumor-Infiltrating Lymphocytes. J. Immunol. 171: 6283-6289 [Abstract] [Full Text]
de Vries, I. J. M., Lesterhuis, W. J., Scharenborg, N. M., Engelen, L. P. H., Ruiter, D. J., Gerritsen, M.-J. P., Croockewit, S., Britten, C. M., Torensma, R., Adema, G. J., Figdor, C. G., Punt, C. J. A. (2003). Maturation of Dendritic Cells Is a Prerequisite for Inducing Immune Responses in Advanced Melanoma Patients. Clin. Cancer Res. 9: 5091-5100 [Abstract] [Full Text]
de Rijke, B., Fredrix, H., Zoetbrood, A., Scherpen, F., Witteveen, H., de Witte, T., van de Wiel-van Kemenade, E., Dolstra, H. (2003). Generation of autologous cytotoxic and helper T-cell responses against the B-cell leukemia-associated antigen HB-1: relevance for precursor B-ALL-specific immunotherapy. Blood 102: 2885-2891 [Abstract] [Full Text]
Odunsi, K., Jungbluth, A. A., Stockert, E., Qian, F., Gnjatic, S., Tammela, J., Intengan, M., Beck, A., Keitz, B., Santiago, D., Williamson, B., Scanlan, M. J., Ritter, G., Chen, Y.-T., Driscoll, D., Sood, A., Lele, S., Old, L. J. (2003). NY-ESO-1 and LAGE-1 Cancer-Testis Antigens Are Potential Targets for Immunotherapy in Epithelial Ovarian Cancer. Cancer Res. 63: 6076-6083 [Abstract] [Full Text]
Tatsumi, T., Herrem, C. J., Olson, W. C., Finke, J. H., Bukowski, R. M., Kinch, M. S., Ranieri, E., Storkus, W. J. (2003). Disease Stage Variation in CD4+ and CD8+ T-Cell Reactivity to the Receptor Tyrosine Kinase EphA2 in Patients with Renal Cell Carcinoma. Cancer Res. 63: 4481-4489 [Abstract] [Full Text]
Matsui, K., O'Mara, L. A., Allen, P. M. (2003). Successful elimination of large established tumors and avoidance of antigen-loss variants by aggressive adoptive T cell immunotherapy. Int Immunol 15: 797-805 [Abstract] [Full Text]
Admon, A., Barnea, E., Ziv, T. (2003). Tumor Antigens and Proteomics from the Point of View of the Major Histocompatibility Complex Peptides. Mol. Cell. Proteomics 2: 388-398 [Abstract] [Full Text]
Palmieri, G., Ascierto, P. A., Perrone, F., Satriano, S. M.R., Ottaiano, A., Daponte, A., Napolitano, M., Caraco, C., Mozzillo, N., Melucci, M. T., Cossu, A., Tanda, F., Gallo, C., Satriano, R. A., Castello, G. (2003). Prognostic Value of Circulating Melanoma Cells Detected by Reverse Transcriptase-Polymerase Chain Reaction. JCO 21: 767-773 [Abstract] [Full Text]
Horiguchi, Y., Nukaya, I., Okazawa, K., Kawashima, I., Fikes, J., Sette, A., Tachibana, M., Takesako, K., Murai, M. (2002). Screening of HLA-A24-restricted Epitope Peptides from Prostate-specific Membrane Antigen That Induce Specific Antitumor Cytotoxic T Lymphocytes. Clin. Cancer Res. 8: 3885-3892 [Abstract] [Full Text]
Espinoza-Delgado, I. (2002). Cancer Vaccines. The Oncologist 7: 20-33 [Abstract] [Full Text]
Wolchok, J. D., Chapman, P. B., Mitchell, M. S. (2002). Phase I Trial of Adoptive Immunotherapy With Cytolytic T Lymphocytes Immunized Against a Tyrosinase Epitope. JCO 20: 3176-3177 [Full Text]
Fang, D., Tsuji, Y., Setaluri, V. (2002). Selective down-regulation of tyrosinase family gene TYRP1 by inhibition of the activity of melanocyte transcription factor, MITF. Nucleic Acids Res 30: 3096-3106 [Abstract] [Full Text]
Dutoit, V., Rubio-Godoy, V., Pittet, M. J., Zippelius, A., Dietrich, P.-Y., Legal, F. A., Guillaume, P., Romero, P., Cerottini, J.-C., Houghten, R. A., Pinilla, C., Valmori, D. (2002). Degeneracy of Antigen Recognition as the Molecular Basis for the High Frequency of Naive A2/Melan-A Peptide Multimer+ CD8+ T Cells in Humans. JEM 196: 207-216 [Abstract] [Full Text]
Linard, B., Bezieau, S., Benlalam, H., Labarriere, N., Guilloux, Y., Diez, E., Jotereau, F. (2002). A ras-Mutated Peptide Targeted by CTL Infiltrating a Human Melanoma Lesion. J. Immunol. 168: 4802-4808 [Abstract] [Full Text]
Mitchell, M. S., Darrah, D., Yeung, D., Halpern, S., Wallace, A., Voland, J., Jones, V., Kan-Mitchell, J. (2002). Phase I Trial of Adoptive Immunotherapy With Cytolytic T Lymphocytes Immunized Against a Tyrosinase Epitope. JCO 20: 1075-1086 [Abstract] [Full Text]
Khong, H. T., Rosenberg, S. A. (2002). Pre-Existing Immunity to Tyrosinase-Related Protein (TRP)-2, a New TRP-2 Isoform, and the NY-ESO-1 Melanoma Antigen in a Patient with a Dramatic Response to Immunotherapy. J. Immunol. 168: 951-956 [Abstract] [Full Text]
Smith, S. G., Patel, P. M., Porte, J., Selby, P. J., Jackson, A. M. (2001). Human Dendritic Cells Genetically Engineered to Express a Melanoma Polyepitope DNA Vaccine Induce Multiple Cytotoxic T-Cell Responses. Clin. Cancer Res. 7: 4253-4261 [Abstract] [Full Text]
Kao, H., Marto, J. A., Hoffmann, T. K., Shabanowitz, J., Finkelstein, S. D., Whiteside, T. L., Hunt, D. F., Finn, O. J. (2001). Identification of Cyclin B1 as a Shared Human Epithelial Tumor-Associated Antigen Recognized by T Cells. JEM 194: 1313-1324 [Abstract] [Full Text]
Mullins, D. W., Bullock, T. N. J., Colella, T. A., Robila, V. V., Engelhard, V. H. (2001). Immune Responses to the HLA-A*0201-Restricted Epitopes of Tyrosinase and Glycoprotein 100 Enable Control of Melanoma Outgrowth in HLA-A*0201-Transgenic Mice. J. Immunol. 167: 4853-4860 [Abstract] [Full Text]
Jager, D, Jager, E, Knuth, A (2001). Immune responses to tumour antigens: implications for antigen specific immunotherapy of cancer. J. Clin. Pathol. 54: 669-674 [Abstract] [Full Text]
Dutoit, V., Rubio-Godoy, V., Dietrich, P.-Y., Quiqueres, A.-L., Schnuriger, V., Rimoldi, D., Lienard, D., Speiser, D., Guillaume, P., Batard, P., Cerottini, J.-C., Romero, P., Valmori, D. (2001). Heterogeneous T-Cell Response to MAGE-A10254-262: High Avidity-specific Cytolytic T Lymphocytes Show Superior Antitumor Activity. Cancer Res. 61: 5850-5856 [Abstract] [Full Text]
Meyer zum Buschenfelde, C., Metzger, J., Hermann, C., Nicklisch, N., Peschel, C., Bernhard, H. (2001). The Generation of Both T Killer and Th Cell Clones Specific for the Tumor-Associated Antigen HER2 Using Retrovirally Transduced Dendritic Cells. J. Immunol. 167: 1712-1719 [Abstract] [Full Text]
Kurashige, T., Noguchi, Y., Saika, T., Ono, T., Nagata, Y., Jungbluth, A., Ritter, G., Chen, Y.-T., Stockert, E., Tsushima, T., Kumon, H., Old, L. J., Nakayama, E. (2001). NY-ESO-1 Expression and Immunogenicity Associated with Transitional Cell Carcinoma: Correlation with Tumor Grade. Cancer Res. 61: 4671-4674 [Abstract] [Full Text]
Trojan, A., Witzens, M., Schultze, J. L., Vonderheide, R. H., Harig, S., Krackhardt, A. M., Stahel, R. A., Gribben, J. G. (2001). Generation of Cytotoxic T Lymphocytes against Native and Altered Peptides of Human Leukocyte Antigen-A*0201 Restricted Epitopes from the Human Epithelial Cell Adhesion Molecule. Cancer Res. 61: 4761-4765 [Abstract] [Full Text]
Machiels, J.-P. H., Reilly, R. T., Emens, L. A., Ercolini, A. M., Lei, R. Y., Weintraub, D., Okoye, F. I., Jaffee, E. M. (2001). Cyclophosphamide, Doxorubicin, and Paclitaxel Enhance the Antitumor Immune Response of Granulocyte/Macrophage-Colony Stimulating Factor-secreting Whole-Cell Vaccines in HER-2/neu Tolerized Mice. Cancer Res. 61: 3689-3697 [Abstract] [Full Text]
Ono, T., Kurashige, T., Harada, N., Noguchi, Y., Saika, T., Niikawa, N., Aoe, M., Nakamura, S., Higashi, T., Hiraki, A., Wada, H., Kumon, H., Old, L. J., Nakayama, E. (2001). Identification of proacrosin binding protein sp32 precursor as a human cancer/testis antigen. Proc. Natl. Acad. Sci. USA 98: 3282-3287 [Abstract] [Full Text]
Jäger, D., Stockert, E., Güre, A. O., Scanlan, M. J., Karbach, J., Jäger, E., Knuth, A., Old, L. J., Chen, Y.-T. (2001). Identification of a Tissue-specific Putative Transcription Factor in Breast Tissue by Serological Screening of a Breast Cancer Library. Cancer Res. 61: 2055-2061 [Abstract] [Full Text]
Frost, P. J., Butterfield, L. H., Dissette, V. B., Economou, J. S., Bonavida, B. (2001). Immunosensitization of Melanoma Tumor Cells to Non-MHC Fas-Mediated Killing by MART-1-Specific CTL Cultures. J. Immunol. 166: 3564-3573 [Abstract] [Full Text]
Vely, F., Peyrat, M.-A., Couedel, C., Morcet, J.-F., Halary, F., Davodeau, F., Romagne, F., Scotet, E., Saulquin, X., Houssaint, E., Schleinitz, N., Moretta, A., Vivier, E., Bonneville, M. (2001). Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements. J. Immunol. 166: 2487-2494 [Abstract] [Full Text]
Kessler, J. H., Beekman, N. J., Bres-Vloemans, S. A., Verdijk, P., van Veelen, P. A., Kloosterman-Joosten, A. M., Vissers, D. C.J., ten Bosch, G. J.A., Kester, M. G.D., Sijts, A., Drijfhout, J. W., Ossendorp, F., Offringa, R., Melief, C. J.M. (2001). Efficient Identification of Novel HLA-A*0201-presented Cytotoxic T Lymphocyte Epitopes in the Widely Expressed Tumor Antigen PRAME by Proteasome-mediated Digestion Analysis. JEM 193: 73-88 [Abstract] [Full Text]
Nishiyama, T., Tachibana, M., Horiguchi, Y., Nakamura, K., Ikeda, Y., Takesako, K., Murai, M. (2001). Immunotherapy of Bladder Cancer Using Autologous Dendritic Cells Pulsed with Human Lymphocyte Antigen-A24-specific MAGE-3 Peptide. Clin. Cancer Res. 7: 23-31 [Abstract] [Full Text]
Shaif-Muthana, M., McIntyre, C., Sisley, K., Rennie, I., Murray, A. (2000). Dead or Alive: Immunogenicity of Human Melanoma Cells When Presented by Dendritic Cells. Cancer Res. 60: 6441-6447 [Abstract] [Full Text]
Chaudhuri, S., Cariappa, A., Tang, M., Bell, D., Haber, D. A., Isselbacher, K. J., Finkelstein, D., Forcione, D., Pillai, S. (2000). Genetic susceptibility to breast cancer: HLA DQB*03032 and HLA DRB1*11 may represent protective alleles. Proc. Natl. Acad. Sci. USA 97: 11451-11454 [Abstract] [Full Text]
Jäger, E., Gnjatic, S., Nagata, Y., Stockert, E., Jäger, D., Karbach, J., Neumann, A., Rieckenberg, J., Chen, Y.-T., Ritter, G., Hoffman, E., Arand, M., Old, L. J., Knuth, A. (2000). Induction of primary NY-ESO-1 immunity: CD8+ T lymphocyte and antibody responses in peptide-vaccinated patients with NY-ESO-1+ cancers. Proc. Natl. Acad. Sci. USA 10.1073/pnas.220413497v1 [Abstract] [Full Text]
Gnjatic, S., Nagata, Y., Jager, E., Stockert, E., Shankara, S., Roberts, B. L., Mazzara, G. P., Lee, S. Y., Dunbar, P. R., Dupont, B., Cerundolo, V., Ritter, G., Chen, Y.-T., Knuth, A., Old, L. J. (2000). Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc. Natl. Acad. Sci. USA 97: 10917-10922 [Abstract] [Full Text]
Nishizaka, S., Gomi, S., Harada, K., Oizumi, K., Itoh, K., Shichijo, S. (2000). A New Tumor-Rejection Antigen Recognized by Cytotoxic T Lymphocytes Infiltrating into a Lung Adenocarcinoma. Cancer Res. 60: 4830-4837 [Abstract] [Full Text]
Kawano, K., Gomi, S., Tanaka, K., Tsuda, N., Kamura, T., Itoh, K., Yamada, A. (2000). Identification of a New Endoplasmic Reticulum-resident Protein Recognized by HLA-A24-restricted Tumor-infiltrating Lymphocytes of Lung Cancer. Cancer Res. 60: 3550-3558 [Abstract] [Full Text]
Jäger, D., Stockert, E., Jäger, E., Güre, A. O., Scanlan, M. J., Knuth, A., Old, L. J., Chen, Y.-T. (2000). Serological Cloning of a Melanocyte rab Guanosine 5'-Triphosphate-binding Protein and a Chromosome Condensation Protein from a Melanoma Complementary DNA Library. Cancer Res. 60: 3584-3591 [Abstract] [Full Text]
Martelange, V., De Smet, C., De Plaen, E., Lurquin, C., Boon, T. (2000). Identification on a Human Sarcoma of Two New Genes with Tumor-specific Expression. Cancer Res. 60: 3848-3855 [Abstract] [Full Text]
Moreau-Aubry, A., Le Guiner, S., Labarriere, N., Gesnel, M.-C., Jotereau, F., Breathnach, R. (2000). A Processed Pseudogene Codes for a New Antigen Recognized by a CD8+ T Cell Clone on Melanoma. JEM 191: 1617-1624 [Abstract] [Full Text]
Robinson, C., Callow, M., Stevenson, S., Scott, B., Robinson, B. W. S., Lake, R. A. (2000). Serologic Responses in Patients with Malignant Mesothelioma . Evidence for Both Public and Private Specificities. Am. J. Respir. Cell Mol. Bio. 22: 550-556 [Abstract] [Full Text]
Ibisch, C., Saulquin, X., Gallot, G., Vivien, R., Ferrand, C., Tiberghien, P., Houssaint, E., Vie, H. (2000). The T Cell Repertoire Selected In Vitro Against EBV: Diversity, Specificity, and Improved Purification Through Early IL-2 Receptor {alpha}-Chain (CD25)-Positive Selection. J. Immunol. 164: 4924-4932 [Abstract] [Full Text]
Jager, E., Nagata, Y., Gnjatic, S., Wada, H., Stockert, E., Karbach, J., Dunbar, P. R., Lee, S. Y., Jungbluth, A., Jager, D., Arand, M., Ritter, G., Cerundolo, V., Dupont, B., Chen, Y.-T., Old, L. J., Knuth, A. (2000). Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses. Proc. Natl. Acad. Sci. USA 97: 4760-4765 [Abstract] [Full Text]
Colella, T. A., Bullock, T. N.J., Russell, L. B., Mullins, D. W., Overwijk, W. W., Luckey, C. J., Pierce, R. A., Restifo, N. P., Engelhard, V. H. (2000). Self-Tolerance to the Murine Homologue of a Tyrosinase-derived Melanoma Antigen: Implications for Tumor Immunotherapy. JEM 191: 1221-1232 [Abstract] [Full Text]
Baxevanis, C. N., Voutsas, I. F., Tsitsilonis, O. E., Gritzapis, A. D., Sotiriadou, R., Papamichail, M. (2000). Tumor-Specific CD4+ T Lymphocytes from Cancer Patients Are Required for Optimal Induction of Cytotoxic T Cells Against the Autologous Tumor. J. Immunol. 164: 3902-3912 [Abstract] [Full Text]
Dzuris, J. L., Sidney, J., Appella, E., Chesnut, R. W., Watkins, D. I., Sette, A. (2000). Conserved MHC Class I Peptide Binding Motif Between Humans and Rhesus Macaques. J. Immunol. 164: 283-291 [Abstract] [Full Text]
Bowne, W. B., Srinivasan, R., Wolchok, J. D., Hawkins, W. G., Blachere, N. E., Dyall, R., Lewis, J. J., Houghton, A. N. (1999). Coupling and Uncoupling of Tumor Immunity and Autoimmunity. JEM 190: 1717-1722 [Abstract] [Full Text]
Wang, S., Bartido, S., Yang, G., Qin, J., Moroi, Y., Panageas, K. S., Lewis, J. J., Houghton, A. N. (1999). A Role for a Melanosome Transport Signal in Accessing the MHC Class II Presentation Pathway and in Eliciting CD4+ T Cell Responses. J. Immunol. 163: 5820-5826 [Abstract] [Full Text]
Chiari, R., Foury, F., De Plaen, E., Baurain, J.-F., Thonnard, J., G. Coulie, P. (1999). Two Antigens Recognized by Autologous Cytolytic T Lymphocytes on a Melanoma Result from a Single Point Mutation in an Essential Housekeeping Gene. Cancer Res. 59: 5785-5792 [Abstract] [Full Text]
Gomi, S., Nakao, M., Niiya, F., Imamura, Y., Kawano, K., Nishizaka, S., Hayashi, A., Sobao, Y., Oizumi, K., Itoh, K. (1999). A Cyclophilin B Gene Encodes Antigenic Epitopes Recognized by HLA-A24-Restricted and Tumor-Specific CTLs. J. Immunol. 163: 4994-5004 [Abstract] [Full Text]
Drexler, I., Antunes, E., Schmitz, M., Wolfel, T., Huber, C., Erfle, V., Rieber, P., Theobald, M., Sutter, G. (1999). Modified Vaccinia Virus Ankara for Delivery of Human Tyrosinase as Melanoma-associated Antigen: Induction of Tyrosinase- and Melanoma-specific Human Leukocyte Antigen A*0201-restricted Cytotoxic T Cells in Vitro and in Vivo. Cancer Res. 59: 4955-4963 [Abstract] [Full Text]
Wang, F., Bade, E., Kuniyoshi, C., Spears, L., Jeffery, G., Marty, V., Groshen, S., Weber, J. (1999). Phase I Trial of a MART-1 Peptide Vaccine with Incomplete Freund's Adjuvant for Resected High-Risk Melanoma. Clin. Cancer Res. 5: 2756-2765 [Abstract] [Full Text]
Yamazaki, K., Spruill, G., Rhoderick, J., Spielman, J., Savaraj, N., Podack, E. R. (1999). Small Cell Lung Carcinomas Express Shared and Private Tumor Antigens Presented by HLA-A1 or HLA-A2. Cancer Res. 59: 4642-4650 [Abstract] [Full Text]
Suzuki, K., Sahara, H., Okada, Y., Yasoshima, T., Hirohashi, Y., Nabeta, Y., Hirai, I., Torigoe, T., Takahashi, S., Matsuura, A., Takahashi, N., Sasaki, A., Suzuki, M., Hamuro, J., Ikeda, H., Wada, Y., Hirata, K., Kikuchi, K., Sato, N. (1999). Identification of Natural Antigenic Peptides of a Human Gastric Signet Ring Cell Carcinoma Recognized by HLA-A31-Restricted Cytotoxic T Lymphocytes. J. Immunol. 163: 2783-2791 [Abstract] [Full Text]
Valmori, D., J. Pittet, M., Vonarbourg, C., Rimoldi, D., Lienard, D., Speiser, D., Dunbar, R., Cerundolo, V., Cerottini, J.-C., Romero, P. (1999). Analysis of the Cytolytic T Lymphocyte Response of Melanoma Patients to the Naturally HLA-A*0201-associated Tyrosinase Peptide 368-376. Cancer Res. 59: 4050-4055 [Abstract] [Full Text]
Yang, D., Nakao, M., Shichijo, S., Sasatomi, T., Takasu, H., Matsumoto, H., Mori, K., Hayashi, A., Yamana, H., Shirouzu, K., Itoh, K. (1999). Identification of a Gene Coding for a Protein Possessing Shared Tumor Epitopes Capable of Inducing HLA-A24-restricted Cytotoxic T Lymphocytes inCancer Patients. Cancer Res. 59: 4056-4063 [Abstract] [Full Text]
Kaplan, J. M., Yu, Q., Piraino, S. T., Pennington, S. E., Shankara, S., Woodworth, L. A., Roberts, B. L. (1999). Induction of Antitumor Immunity with Dendritic Cells Transduced with Adenovirus Vector-Encoding Endogenous Tumor-Associated Antigens. J. Immunol. 163: 699-707 [Abstract] [Full Text]
Rongcun, Y., Salazar-Onfray, F., Charo, J., Malmberg, K.-J., Evrin, K., Maes, H., Kono, K., Hising, C., Petersson, M., Larsson, O., Lan, L., Appella, E., Sette, A., Celis3, E., Kiessling, R. (1999). Identification of New HER2/neu-Derived Peptide Epitopes That Can Elicit Specific CTL Against Autologous and Allogeneic Carcinomas and Melanomas. J. Immunol. 163: 1037-1044 [Abstract] [Full Text]
Ronsin, C., Chung-Scott, V., Poullion, I., Aknouche, N., Gaudin, C., Triebel, F. (1999). A Non-AUG-Defined Alternative Open Reading Frame of the Intestinal Carboxyl Esterase mRNA Generates an Epitope Recognized by Renal Cell Carcinoma-Reactive Tumor-Infiltrating Lymphocytes In Situ. J. Immunol. 163: 483-490 [Abstract] [Full Text]
Evans, T.R.J., Kaye, S.B. (1999). Vaccine therapy for cancer�fact or fiction?. QJM 92: 299-307 [Full Text]
Tanzarella, S., Russo, V., Lionello, I., Dalerba, P., Rigatti, D., Bordignon, C., Traversari, C. (1999). Identification of a Promiscuous T-Cell Epitope Encoded by Multiple Members of the MAGE Family. Cancer Res. 59: 2668-2674 [Abstract] [Full Text]
Huang, L.-Q., Brasseur, F., Serrano, A., De Plaen, E., van der Bruggen, P., Boon, T., Van Pel, A. (1999). Cytolytic T Lymphocytes Recognize an Antigen Encoded by MAGE-A10 on a Human Melanoma. J. Immunol. 162: 6849-6854 [Abstract] [Full Text]
Maitre, N., Brown, J. M., Demcheva, M., Kelley, J. R., Lockett, M. A., Vournakis, J., Cole, D. J. (1999). Primary T-Cell and Activated Macrophage Response Associated with Tumor Protection Using Peptide/Poly-N-Acetyl Glucosamine Vaccination. Clin. Cancer Res. 5: 1173-1182 [Abstract] [Full Text]
Saijo, Y., Hong, X., Tanaka, M., Tazawa, R., Liu, S. Q., Saijo, K., Ohno, T., Koike, K., Ohkuda, K., Satoh, K., Nukiwa, T. (1999). Autologous High-Killing Cytotoxic T Lymphocytes against Human Lung Cancer Are Induced Using Interleukin (IL)-1{beta}, IL-2, IL-4, and IL-6: Possible Involvement of Dendritic Cells. Clin. Cancer Res. 5: 1203-1209 [Abstract] [Full Text]
Fayolle, C., Ladant, D., Karimova, G., Ullmann, A., Leclerc, C. (1999). Therapy of Murine Tumors with Recombinant Bordetella pertussis Adenylate Cyclase Carrying a Cytotoxic T Cell Epitope. J. Immunol. 162: 4157-4162 [Abstract] [Full Text]
Baar, J. (1999). Clinical Applications of Dendritic Cell Cancer Vaccines. The Oncologist 4: 140-144 [Full Text]
Men, Y., Miconnet, I., Valmori, D., Rimoldi, D., Cerottini, J.-C., Romero, P. (1999). Assessment of Immunogenicity of Human Melan-A Peptide Analogues in HLA-A*0201/Kb Transgenic Mice. J. Immunol. 162: 3566-3573 [Abstract] [Full Text]
Edinger, J. W., Bonneville, M., Scotet, E., Houssaint, E., Schumacher, H. R., Posnett, D. N. (1999). EBV Gene Expression Not Altered in Rheumatoid Synovia Despite the Presence of EBV Antigen-Specific T Cell Clones. J. Immunol. 162: 3694-3701 [Abstract] [Full Text]
Greten, T. F., Jaffee, E. M. (1999). Cancer Vaccines. JCO 17: 1047-1047 [Abstract] [Full Text]
Pieper, R., Christian, R. E., Gonzales, M. I., Nishimura, M. I., Gupta, G., Settlage, R. E., Shabanowitz, J., Rosenberg, S. A., Hunt, D. F., Topalian, S. L. (1999). Biochemical Identification of a Mutated Human Melanoma Antigen Recognized by CD4+ T Cells. JEM 189: 757-766 [Abstract] [Full Text]
Sarma, S., Guo, Y., Guilloux, Y., Lee, C., Bai, X.-F., Liu, Y. (1999). Cytotoxic T Lymphocytes to An Unmutated Tumor Rejection Antigen P1A: Normal Development but Restrained Effector Function In Vivo. JEM 189: 811-820 [Abstract] [Full Text]